What does CUSIP 18914F103 represent in this 13F holders report?

CUSIP 18914F103 is the security identifier for CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock used to aggregate holder disclosures.

How many institutions held CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in Q1 2022?

147 institutional investors reported CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock for Q1 2022. Use the holders table for investor-level position and value details.

CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock
Shares outstanding: 416,598,522
Total 13F shares: 99,563,575
Share change: -30,653,452
Total reported value: $353,476,882
Put/Call ratio: 112%
Price per share: $3.55
Number of holders: 147
Value change: -$114,782,509
Number of buys: 81
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 18914F103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	6.2%	25,887,351	$96,302,000	—	31 Dec 2021	13F
GREENOAKS CAPITAL PARTNERS LLC	13F 3/4/5	Company · Other*, 10%+ Owner	6%	24,847,610	$92,433,000	—	31 Dec 2021	13F 3/4/5
Chamath Palihapitiya	3/4/5	FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner	— class O/S missing	30,147,610	$29,544,657	—	07 Jul 2021	3/4/5
BAILLIE GIFFORD & CO	13F	Company	1.9%	7,787,680	$28,970,000	—	31 Dec 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.6%	6,609,628	$24,588,000	—	31 Dec 2021	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	1.5%	6,361,917	$23,666,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	1.3%	5,351,416	$19,907,000	—	31 Dec 2021	13F
Ghisallo Capital Management LLC	13F	Company	1.3%	5,297,006	$19,705,000	—	31 Dec 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.2%	5,052,286	$18,794,000	—	31 Dec 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.1%	4,378,700	$16,289,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.86%	3,589,146	$13,352,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.58%	2,403,839	$8,942,000	—	31 Dec 2021	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.52%	2,180,000	$8,110,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0.48%	2,001,683	$7,447,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	0.43%	1,790,044	$6,659,000	—	31 Dec 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.42%	1,737,366	$6,463,000	—	31 Dec 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.39%	1,632,482	$6,073,000	—	31 Dec 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.38%	1,598,145	$5,945,000	—	31 Dec 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.36%	1,500,000	$5,580,000	—	31 Dec 2021	13F
Hudson Structured Capital Management Ltd.	13F	Company	0.36%	1,491,805	$5,550,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.34%	1,402,098	$5,215,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.32%	1,336,988	$4,974,000	—	31 Dec 2021	13F
MARSHALL WACE, LLP	13F	Company	0.3%	1,245,630	$4,633,000	—	31 Dec 2021	13F
HRT FINANCIAL LP	13F	Company	0.29%	1,222,196	$4,546,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.2%	830,982	$3,092,000	—	31 Dec 2021	13F
CITIGROUP INC	13F	Company	0.2%	812,386	$3,022,000	—	31 Dec 2021	13F
Qube Research & Technologies Ltd	13F	Company	0.19%	800,391	$2,977,000	—	31 Dec 2021	13F
Paloma Partners Management Co	13F	Company	0.17%	708,008	$2,634,000	—	31 Dec 2021	13F
Swiss National Bank	13F	Company	0.16%	654,500	$2,435,000	—	31 Dec 2021	13F
BANK OF MONTREAL /CAN/	13F	Company	0.13%	541,400	$2,079,000	—	31 Dec 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.12%	520,258	$1,935,000	—	31 Dec 2021	13F
EQUITEC PROPRIETARY MARKETS, LLC	13F	Company	0.12%	495,375	$1,843,000	—	31 Dec 2021	13F
MSD Partners, L.P.	13F	Company	0.11%	442,143	$1,644,000	—	31 Dec 2021	13F
Comprehensive Financial Management LLC	13F	Company	0.1%	428,864	$1,595,000	—	31 Dec 2021	13F
CAPITAL FUND MANAGEMENT S.A.	13F	Company	0.1%	404,671	$1,505,376	—	31 Dec 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.09%	391,727	$1,457,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.09%	368,509	$1,371,000	—	31 Dec 2021	13F
Nathaniel S. Turner	3/4/5	Director	— class O/S missing	1,324,728	$1,258,492	—	07 Jan 2021	3/4/5
ExodusPoint Capital Management, LP	13F	Company	0.08%	318,901	$1,186,000	—	31 Dec 2021	13F
Alpine Global Management, LLC	13F	Company	0.07%	273,829	$1,019,000	—	31 Dec 2021	13F
SAGE RHINO CAPITAL LLC	13F	Company	0.06%	261,500	$973,000	—	31 Dec 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	252,410	$939,000	—	31 Dec 2021	13F
Engineers Gate Manager LP	13F	Company	0.06%	250,284	$931,000	—	31 Dec 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.06%	246,976	$918,752	—	31 Dec 2021	13F
Squarepoint Ops LLC	13F	Company	0.06%	234,971	$874,000	—	31 Dec 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	234,686	$873,000	—	31 Dec 2021	13F
Summit Rock Advisors, LP	13F	Company	0.05%	210,639	$784,000	—	31 Dec 2021	13F
CREDIT SUISSE AG/	13F	Company	0.04%	186,567	$695,000	—	31 Dec 2021	13F
Mission Creek Capital Partners, Inc.	13F	Company	0.04%	182,325	$678,000	—	31 Dec 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0.04%	176,455	$658,000	—	31 Dec 2021	13F

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q1 2022

As of 31 Mar 2022, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by 147 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,563,575 shares. The largest 10 holders included VANGUARD GROUP INC, BAILLIE GIFFORD & CO, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PNC Financial Services Group, Inc., BlackRock Inc., TWO SIGMA ADVISERS, LP, D. E. Shaw & Co., Inc., TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC. This page lists 148 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

144

Q1 2022 holders

147

Holder diff

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.